Published in Oncogene on November 12, 2007
TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol (2010) 4.92
p53 polymorphisms: cancer implications. Nat Rev Cancer (2009) 3.33
Mutational spectra of human cancer. Hum Genet (2009) 2.26
An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model. Genes Dev (2016) 1.70
The codon 72 polymorphism of p53 regulates interaction with NF-{kappa}B and transactivation of genes involved in immunity and inflammation. Mol Cell Biol (2011) 1.20
How to become immortal: let MEFs count the ways. Aging (Albany NY) (2010) 1.14
Regulation of female reproduction by p53 and its family members. FASEB J (2011) 1.08
Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid. Mutat Res (2013) 1.02
Modelling mutational landscapes of human cancers in vitro. Sci Rep (2014) 0.99
Wild-type and Hupki (human p53 knock-in) murine embryonic fibroblasts: p53/ARF pathway disruption in spontaneous escape from senescence. J Biol Chem (2010) 0.97
Applications of the human p53 knock-in (Hupki) mouse model for human carcinogen testing. FASEB J (2010) 0.94
Tissue-specific apoptotic effects of the p53 codon 72 polymorphism in a mouse model. Cell Cycle (2011) 0.93
TP53 mutations induced by BPDE in Xpa-WT and Xpa-Null human TP53 knock-in (Hupki) mouse embryo fibroblasts. Mutat Res (2015) 0.89
Efficient introduction of specific TP53 mutations into mouse embryonic fibroblasts and embryonic stem cells. Nat Protoc (2012) 0.85
The genome as a record of environmental exposure. Mutagenesis (2015) 0.85
Regulation of Fertility by the p53 Family Members. Genes Cancer (2011) 0.82
TP53 and lacZ mutagenesis induced by 3-nitrobenzanthrone in Xpa-deficient human TP53 knock-in mouse embryo fibroblasts. DNA Repair (Amst) (2015) 0.80
Comparison of the metabolic activation of environmental carcinogens in mouse embryonic stem cells and mouse embryonic fibroblasts. Toxicol In Vitro (2014) 0.79
Unveiling the methylation status of CpG dinucleotides in the substituted segment of the human p53 knock-in (Hupki) mouse genome. Mol Carcinog (2010) 0.78
Benzo[a]pyrene, aflatoxine B₁ and acetaldehyde mutational patterns in TP53 gene using a functional assay: relevance to human cancer aetiology. PLoS One (2012) 0.75
Evaluation of in vivo mutagenesis for assessing the health risk of air pollutants. Genes Environ (2017) 0.75
Raster3D Version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr D Biol Crystallogr (1994) 17.44
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res (1994) 11.29
Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species. Science (2001) 10.93
Clinical implications of the p53 tumor-suppressor gene. N Engl J Med (1993) 7.29
p53 and human cancer: the first ten thousand mutations. Adv Cancer Res (2000) 4.71
RNAi as random degradative PCR: siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNAs. Cell (2001) 3.80
IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res (1998) 3.74
Visualization of melanosome dynamics within wild-type and dilute melanocytes suggests a paradigm for myosin V function In vivo. J Cell Biol (1998) 3.21
Directed assembly of one-dimensional nanostructures into functional networks. Science (2001) 3.21
A new Salmonella tester strain (TA102) with A X T base pairs at the site of mutation detects oxidative mutagens. Proc Natl Acad Sci U S A (1982) 2.67
Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res (2001) 2.37
Urolithiasis in pediatric patients. Mayo Clin Proc (1993) 2.28
Myosin V associates with melanosomes in mouse melanocytes: evidence that myosin V is an organelle motor. J Cell Sci (1997) 2.24
Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects. Nucleic Acids Res (1997) 2.17
Polymorphisms in the p53 pathway. Oncogene (2006) 2.06
Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst (2001) 2.06
Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis. Oncogene (2006) 1.82
Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer (1996) 1.82
The p53 family and programmed cell death. Oncogene (2008) 1.81
Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res (2000) 1.73
Short-term tests for carcinogens and mutagens. Mutat Res (1979) 1.62
Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool. Oncogene (2001) 1.57
Two high-resolution crystal structures of the recombinant N-lobe of human transferrin reveal a structural change implicated in iron release. Biochemistry (1998) 1.57
Antioxidant defense systems: the role of carotenoids, tocopherols, and thiols. Am J Clin Nutr (1991) 1.54
Geographic variation of p53 mutational profile in nonmalignant human liver. Science (1994) 1.51
Genetic susceptibility to tobacco carcinogenesis. Cancer Invest (1999) 1.48
Clinical implications of the p53 gene. Annu Rev Med (1996) 1.38
Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int J Cancer (2000) 1.37
Diagnostic value of serum gamma-glutamyl transferase isoenzyme for hepatocellular carcinoma: a 10-year study. Am J Gastroenterol (1992) 1.37
Chromosomal assignment of the human erythropoietin gene and its DNA polymorphism. Proc Natl Acad Sci U S A (1986) 1.36
Strong strain hardening in nanocrystalline nickel. Phys Rev Lett (2009) 1.34
Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation. EMBO J (1999) 1.33
Thymic cortical epithelium is sufficient for the development of mature T cells in relB-deficient mice. J Immunol (1997) 1.33
Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4. EMBO J (1999) 1.32
Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res (2001) 1.29
Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev (1998) 1.28
Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis. Carcinogenesis (2000) 1.26
Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis (1999) 1.25
Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge. Vaccine (1999) 1.25
Improving performance in diabetes care: a multicomponent intervention. Eff Clin Pract (2001) 1.25
Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1. J Virol (1995) 1.25
XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis (2000) 1.25
Lift-off PMN-PT Thick Film for High Frequency Ultrasonic Biomicroscopy. J Am Ceram Soc (2010) 1.24
An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Res (2001) 1.21
Structure of recombinant human renin, a target for cardiovascular-active drugs, at 2.5 A resolution. Science (1989) 1.19
Dietary fish oil and pectin enhance colonocyte apoptosis in part through suppression of PPARdelta/PGE2 and elevation of PGE3. Carcinogenesis (2007) 1.19
Unusual profile and high prevalence of p53 mutations in esophageal squamous cell carcinomas from northern Iran. Cancer Res (2001) 1.17
Impact of a diabetes electronic management system on the care of patients seen in a subspecialty diabetes clinic. Diabetes Care (1998) 1.16
Transfusion-acquired, autochthonous human babesiosis in Japan: isolation of Babesia microti-like parasites with hu-RBC-SCID mice. J Clin Microbiol (2000) 1.15
Anti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride. J Natl Cancer Inst (1995) 1.15
Inactivation of the p53 protein in cell lines derived from human esophageal cancers. Int J Cancer (1997) 1.13
Myosin Va associates with microtubule-rich domains in both interphase and dividing cells. Cell Motil Cytoskeleton (1998) 1.13
HLA-B27 polymorphism in patients with juvenile and adult-onset ankylosing spondylitis in Southern China. Tissue Antigens (2010) 1.13
Current concepts in contrast media-induced nephropathy. AJR Am J Roentgenol (1998) 1.10
Gene expression in human peripheral blood mononuclear cells upon acute ischemic stroke. J Neurol (2008) 1.09
Progression of basal cell carcinoma through loss of chromosome 9q and inactivation of a single p53 allele. Cancer Res (1994) 1.09
Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study. Cancer Res (2001) 1.08
DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis. Lung Cancer (2004) 1.08
Presence of an EcoRI RFLP of the c-mos locus in normal and tumor tissue of esophageal cancer patients. Nucleic Acids Res (1986) 1.08
Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC. Oncogene (2009) 1.07
Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer (2001) 1.06
X-ray structure and site-directed mutagenesis of a nitrite reductase from Alcaligenes faecalis S-6: roles of two copper atoms in nitrite reduction. Biochemistry (1994) 1.06
Correlation between renal vascular resistance, pulse pressure, and the resistive index in isolated perfused rabbit kidneys. Radiology (1999) 1.06
Human babesiosis in Japan: epizootiologic survey of rodent reservoir and isolation of new type of Babesia microti-like parasite. J Clin Microbiol (2001) 1.05
A common polymorphism in the 3'UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population. Lung Cancer (2005) 1.05
Dimerization specificity of myogenic helix-loop-helix DNA-binding factors directed by nonconserved hydrophilic residues. Genes Dev (1993) 1.05
Low-dose genistein induces cyclin-dependent kinase inhibitors and G(1) cell-cycle arrest in human prostate cancer cells. Mol Carcinog (2000) 1.04
Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis (2001) 1.04
A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer. Oncogene (2006) 1.03
The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway. Oncogene (2007) 1.03
Expression in normal human tissues of five nucleotide excision repair genes measured simultaneously by multiplex reverse transcription-polymerase chain reaction. Cancer Epidemiol Biomarkers Prev (1999) 1.02
Advanced glycation end-products enhance calcification in vascular smooth muscle cells. J Int Med Res (2009) 1.02
Cyclin D1 polymorphism and increased risk of colorectal cancer at young age. J Natl Cancer Inst (2001) 1.01
Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of mdm2 amplification in human esophageal carcinomas. Mol Carcinog (1993) 1.01
Catalytic roles for two water bridged residues (Asp-98 and His-255) in the active site of copper-containing nitrite reductase. J Biol Chem (2000) 1.01
A novel XPF -357A>C polymorphism predicts risk and recurrence of bladder cancer. Oncogene (2010) 1.01
Genital infection of female chimpanzees with human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (1998) 1.01
Glutathione-S-transferase polymorphisms and risk of squamous-cell carcinoma of the head and neck. Int J Cancer (1999) 1.00
Novel genetic environment of the plasmid-mediated KPC-3 gene detected in Escherichia coli and Citrobacter freundii isolates from China. Eur J Clin Microbiol Infect Dis (2010) 1.00
Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study. Cancer Epidemiol Biomarkers Prev (2001) 0.99
Safety of mycophenolate mofetil versus azathioprine in renal transplantation: a systematic review. Transplant Proc (2004) 0.98
E-box- and MEF-2-independent muscle-specific expression, positive autoregulation, and cross-activation of the chicken MyoD (CMD1) promoter reveal an indirect regulatory pathway. Mol Cell Biol (1994) 0.98
Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis. Cancer Res (2001) 0.97
REV3L 3'UTR 460 T>C polymorphism in microRNA target sites contributes to lung cancer susceptibility. Oncogene (2012) 0.97
Structure and site-directed mutagenesis of a flavoprotein from Escherichia coli that reduces nitrocompounds: alteration of pyridine nucleotide binding by a single amino acid substitution. J Biol Chem (2000) 0.95
DNA repair: a double-edged sword. J Natl Cancer Inst (2000) 0.94
Chromosomal localization of the human gene for brain Ca2+/calmodulin-dependent protein kinase type IV. Genomics (1989) 0.94
Efficacy of an energy conservation course for persons with multiple sclerosis. Arch Phys Med Rehabil (2001) 0.94
Differences in imaging characteristics of HPV-positive and HPV-Negative oropharyngeal cancers: a blinded matched-pair analysis. AJNR Am J Neuroradiol (2013) 0.93
Polymorphic hCHK2/hCds1 codon 84 allele and risk of squamous cell carcinoma of the head and neck--a case-control analysis. Carcinogenesis (2001) 0.93
Selective lack of intercellular communication between transformed and nontransformed cells as a common property of chemical and oncogene transformation of BALB/c 3T3 cells. Cancer Res (1987) 0.93
Human immunodeficiency virus type 1 intersubtype (B/E) recombination in a superinfected chimpanzee. J Virol (1997) 0.92
Site-directed mutagenesis of azurin from Pseudomonas aeruginosa enhances the formation of an electron-transfer complex with a copper-containing nitrite reductase from Alcaligenes faecalis S-6. FEBS Lett (1996) 0.92
Mutagen sensitivity and risk of gliomas: a case-control analysis. Cancer Res (1996) 0.92
UV-induced DNA damage and mutations in Hupki (human p53 knock-in) mice recapitulate p53 hotspot alterations in sun-exposed human skin. Cancer Res (2001) 0.91
Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes. Br J Cancer (2003) 0.91
Physical and chemical scavenging of singlet molecular oxygen by tocopherols. Arch Biochem Biophys (1990) 0.91
E2A-ZNF384 and NOL1-E2A fusion created by a cryptic t(12;19)(p13.3; p13.3) in acute leukemia. Leukemia (2008) 0.91
Possible contribution of basement membrane to the structural rigidity of blood capillaries. Microvasc Res (1975) 0.91